Anrikefon versus nalbuphine for pain control after eye surgery
Official title: Efficacy and Safety of Anrikefon for Postoperative Analgesia in Ophthalmic Surgery: A Multicenter, Randomized, Parallel-Control, Non-Inferiority Trial
Run by Zhongshan Ophthalmic Center, Sun Yat-sen University · NCT07269106 · Data updated 2026-11-12
This trial will test whether Anrikefon provides pain relief as well as nalbuphine for adults having eye surgery under general anesthesia.
Quick facts
| Phase | Phase 4 |
|---|---|
| Study type | Interventional |
| Ages | 18 Years to 70 Years |
| Sex | All |
| Enrollment | 204 (estimated) |
| Sponsor | Zhongshan Ophthalmic Center, Sun Yat-sen University Academic / other |
| Locations | 3 sites (Guangzhou, Guangdong and 2 other locations) |
| Status | Recruiting |
| Started | January 22, 2026 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | April 1, 2026 |
| Trial ID | NCT07269106 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults 18–70 years old with ASA physical status I–III, BMI 18–30 kg/m², scheduled for ophthalmic surgery under general anesthesia who can give written informed consent are ideal candidates.
✕Probably not a fit
Patients with recent cardiovascular or cerebrovascular events, severe respiratory disease, major neurological or psychiatric disorders, known allergy to kappa opioid agonists or the anesthetic agents used in the study, or other listed exclusion conditions (such as active peptic ulcer disease) are unlikely to benefit and are excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–70 undergoing ophthalmic surgery under general anesthesia will receive an intravenous dose of either Anrikefon or nalbuphine during the perioperative period and will be followed for pain, side effects, and recovery. The phase 4 interventional comparison is designed to determine whether Anrikefon is not inferior to nalbuphine for postoperative analgesia while producing fewer central side effects such as sedation or dizziness. Researchers will record pain scores, adverse events, and recovery metrics including time to discharge after day-surgery procedures, with follow-up assessments to capture safety and recovery outcomes. Results will help determine if Anrikefon can offer effective and safer perioperative pain management for ophthalmic day-surgery patients.
Why it matters
Potential benefit: If successful, Anrikefon could provide effective postoperative pain relief with fewer central nervous system side effects and potentially faster recovery and discharge for eye surgery patients.
How similar studies have gone: Nalbuphine is an established option for perioperative analgesia, while kappa-opioid agents like Anrikefon have been explored in other settings but have limited published data specifically in ophthalmic day-surgery.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Scheduled for ophthalmic surgery under general anesthesia. * Aged 18 to 70 years. * With American Society of Anesthesiologists (ASA) physical status I to III. * Body mass index (BMI) between 18 and 30 kg/m² * Agree to participate in the trial and provide written informed consent. Exclusion Criteria: * History of cardiovascular or cerebrovascular events within the past 6 months, including unstable angina, ischemic myocardial infarction, or heart failure; or current presence of uncontrolled hypertension (\>180/110 mmHg), aneurysm, or severe cardiac arrhythmia. * Severe respiratory diseases such as pulmonary fibrosis, severe pulmonary abscess, cor pulmonale, or advanced chronic obstructive pulmonary disease (COPD). * Significant neurological disorders such as brain injury or seizures, as well as severe psychiatric illnesses. * Known allergy to kappa opioid receptor agonists or to general anesthetic agents used in this study. * Current peptic ulcer disease, gastrointestinal bleeding, or known hypersensitivity to nonsteroidal anti-inflammatory drugs (NSAIDs), such as flurbiprofen axetil or paracetamol. * Prior use of opioid or non-opioid analgesics, with the last administration occurring within five half-life periods of the drug. * Continuous use of opioid analgesics for more than 10 days within the 3 months prior to screening. * Use of drugs with unknown half-life periods that may affect analgesic efficacy within 14 days before randomization. * History of major surgery within the past 3 months that may interfere with postoperative pain assessment.
Where it's running
-
Zhongshan Ophthalmic Center, Sun Yat-Sen University
Guangzhou, Guangdong, China Recruiting -
The Affiliated Hospital of Yunnan University
Kunming, Yunnan, China Not yet recruiting -
Eye & ENT Hospital of Fudan University
Shanghai, China Not yet recruiting
Study contacts
- Study coordinator: Xiaoliang Gan, PhD
- Email: ganxl@mail.sysu.edu.cn
- Phone: 0086-13688893908
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Lower vs higher ketamine doses to reduce the oculocardiac reflex in eye surgery
A single-dose comparison tests whether 0.5 mg/kg IV ketamine works as well as 0.75 mg/kg IV for lowering the oculocardiac reflex in adults having eye surgery.
-
Postoperative Pain Management in Thoracic Surgery
This study tests how well pain control methods work after thoracic surgery for adults, especially when epidural analgesia isn’t possible.
-
Comparison of two chest wall blocks for pain after VATS
Doctors test whether the rhomboid intercostal plane block or the SPSIP block better relieves pain after video-assisted thoracoscopic surgery in adults.
-
mTLIP versus QIPB for pain relief after lumbar microdiscectomy
This study will test whether the modified thoracolumbar interfascial plane block (mTLIP) or the quadro-iliac plane block (QIPB) provides better pain relief for adults having lumbar microdiscectomy surgery.
-
Sensory mapping of two nerve blocks for laparoscopic gallbladder surgery
We will test whether two regional nerve blocks (External Oblique Plane and Serratus Intercostal Plane) produce different skin numbness patterns in adults having elective laparoscopic gallbladder removal.
-
Continuous nefopam infusion after pancreatoduodenectomy
This trial will test whether a continuous infusion of nefopam can lower opioid use and reduce pain for people having a pancreatoduodenectomy.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.